Predictors of edge stenosis after paclitaxel-eluting stent implantation

被引:3
|
作者
Kang, Woong Chol [1 ]
Park, Yae Min [1 ]
Shin, Kwen-Chul [1 ]
Moon, Chan Il [1 ]
Shin, Mi Seung [1 ]
Lee, Kyounghoon [1 ]
Han, Seung Hwan [1 ]
Ahn, Taehoon [1 ]
Shin, Eak Kyun [1 ]
机构
[1] Gachon Univ Med & Sci, Dept Cardiol, Gil Hosp, Inchon 405760, South Korea
关键词
edge stenosis; intravascular ultrasound; paclitaxel-eluting stent; SERIAL INTRAVASCULAR ULTRASOUND; TAXUS-II TRIAL; INTIMAL HYPERPLASIA; CORONARY INTERVENTIONS; DIABETES-MELLITUS; RESTENOSIS; RESPONSES; ANGIOPLASTY; BALLOON; IMPACT;
D O I
10.1097/MCA.0b013e328343fbff
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Although edge stenosis (ES) is a main limitation of drug-eluting stents, the predictors for ES are not well known. We evaluated the predictors for ES after paclitaxel-eluting stent implantation. Methods One hundred and eleven angina patients (64 men; 62.2 +/- 8.4 years of age) were divided into ES (n = 9) and non-ES groups (n = 102). The clinical findings, procedural factors, and intravascular ultrasound (IVUS) parameters were analyzed. Results Although clinical characteristics were not different between groups, diabetes mellitus (DM) was more common in the ES group (P = 0.002). The vessel, plaque, and lumen areas of the lesions were not different between groups; however, the vessel area of the proximal and distal reference artery was smaller in the ES group. Lesions with positive remodeling were more common in the ES group (P = 0.015). On the basis of univariate analysis, predictors of ES included DM, lesions with positive remodeling, IVUS parameters, and procedural factors. After adjusting for clinical findings, angiographic factors, and IVUS parameters, the presence of DM [odds ratio (OR): 9.20; 95% confidence interval (CI): 1.40-60.62, P = 0.021] and lesions with positive remodeling (OR: 5.93; 95% CI: 1.13-31.02, P = 0.035) were independent predictors of ES. The lumen area in the distal 1mm reference segment was a protective factor for ES (OR: 0.05; 95% CI: 0.00-0.74, P = 0.029). Conclusion The risk of ES after paclitaxel-eluting stent implantation was higher in patients who had DM and lesions with positive remodeling. Of the IVUS parameters, the lumen area in the distal 1 mm reference segment was a protective factor against ES. Coron Artery Dis 22:59-63 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 50 条
  • [41] Uniform Vessel Healing after Everolimus-eluting Stent implantation: Detailed Comparison with Paclitaxel-eluting Stent by Optical Coherence Tomography
    Osue, Tsuyoshi
    Shite, Junya
    Shinke, Toshirou
    Otake, Hiromasa
    Nakagawa, Masayuki
    Nagoshi, Ryouji
    Inoue, Takumi
    Kozuki, Amane
    Hariki, Hirotoshi
    Iwasaki, Masamichi
    Taniguchi, Yu
    Kinutani, Hirota
    Konishi, Akihide
    Nishio, Ryo
    Hiranuma, Noritoshi
    Hiratam, Ken-ichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B180 - B180
  • [42] High incidence of thrombus formation at 18 months after paclitaxel-eluting stent implantation: Angioscopic comparison with sirolimus-eluting stent
    Hara, Masahiko
    Nishino, Masami
    Taniike, Masayuki
    Makino, Nobuhiko
    Kato, Hiroyasu
    Egami, Yasuyuki
    Shutta, Ryu
    Yamaguchi, Hitoshi
    Tanouchi, Jun
    Yamada, Yoshio
    AMERICAN HEART JOURNAL, 2010, 159 (05) : 905 - 910
  • [43] Aneurysm formation after paclitaxel-eluting coronary stent implanation
    Tsai, Jui-Peng
    Wang, Kuang-Te
    Yeh, Hung-I
    Hou, Charles Jia-Yin
    ACTA CARDIOLOGICA SINICA, 2007, 23 (01) : 50 - 55
  • [44] Sirolimus-eluting Versus Paclitaxel-eluting Coronary Stent Implantation in Patients with Diabetes Mellitus
    Maeng, Michael
    Jensen, Lisette O.
    Galloe, Anders M.
    Thayssen, Per
    Christiansen, Evald H.
    Kelbaek, Henning
    Botker, Hans E.
    Lassen, Jens F.
    Thuesen, Leif
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 160I - 160I
  • [45] Incidence and predictors of stent thrombosis after paclitaxel and sirolimus-eluting stent implantation in the "real world"
    Iakovou, I
    Sangiorgi, G
    Schmidt, T
    Stankovic, G
    Airoldi, F
    Chieffo, A
    Gerckens, U
    Grube, E
    Colombo, A
    CIRCULATION, 2004, 110 (17) : 688 - 688
  • [47] Clinical and angiographic outcomes of paclitaxel-eluting stent implantation in patients on maintenance hemodialysis
    Kozuma, K.
    Otsuka, M.
    Ikari, Y.
    Uehara, Y.
    Yokoi, H.
    Sano, K.
    Tanabe, K.
    Kimura, K.
    Yamane, M.
    Ishiwata, S.
    EUROPEAN HEART JOURNAL, 2013, 34 : 216 - 216
  • [48] Final minimal stent area is the intravascular ultrasound predictor of angiographic restenosis after paclitaxel-eluting stent implantation.
    Kim, J. S.
    Cho, J. R.
    Paik, S. L.
    Yoo, J. W.
    Ko, Y. G.
    Choi, D.
    Jang, Y.
    Shim, W. H.
    Cho, S. Y.
    Kang, W. C.
    Ah, T. H.
    Kim, B. X.
    Oh, S. J.
    Cheon, D. W.
    Yang, J. Y.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08): : 56F - 56F
  • [49] Comparative Healing Response After Sirolimus- and Paclitaxel-eluting Stent Implantation in a Pig Model of Restenosis
    Silva, Guilherme V.
    Fernandes, Marlos R.
    Madonna, Rosella
    Clubb, Fred
    Oliveira, Edie
    Jimenez-Quevedo, Pilar
    Branco, Rodrigo
    Lopez, Javier
    Angeli, Franca S.
    Sanz-Ruiz, Ricardo
    Vaughn, William K.
    Zheng, Yi
    Baimbridge, Fred
    Canales, John
    Cardoso, Cristiano O.
    Assad, Joao A.
    Falotico, Robert
    Perin, Emerson C.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 73 (06) : 801 - 808
  • [50] Coronary vasomotion one year after drug eluting stent implantation: comparison of everolimus-eluting and paclitaxel-eluting coronary stents
    Hamilos, M.
    Ribichini, F.
    Ostojic, M.
    Ferrero, V.
    Orlic, D.
    Vassanelli, C.
    Karanovic, N.
    Cuisset, T.
    Vardas, P.
    Wijns, W.
    EUROPEAN HEART JOURNAL, 2011, 32 : 202 - 202